The report “Microfluidics
Market by Material (Polymer, Glass, Silicon) Application (Pharmaceutical
(Genomics, Proteomics, Capillary Electrophoresis) Diagnostic (POC, Clinical,
Environmental, Industrial) Drug Delivery (Inhaler, Micropump)) - Global
Forecast to 2020” The Global Microfluidics Market Is Valued at ~$3 Billion
Browse 123 market data tables and 32 figures spread through 200 pages and in-depth TOC on “Microfluidics Market"
will receive 10% customization on this report.
The Microfluidics market is expected to reach $7.5 Billion
by 2020 from $3.1 Billion in 2015, at a CAGR of 19.3%. The microfluidics market
witnessed healthy growth during the last decade due to the growing
pharmaceutical and biotechnology research funding, rising incidences of
lifestyle diseases, and rising geriatric population, globally.
However, high prices of microfluidic proteomic and genomic
analysis platforms, low market visibility of microfluidic products currently
available in the market, and reluctance among researchers to use microfluidic
technology products are inhibiting the growth of this market to a certain
Get The Sample Copy Of This Report:
In this report, the microfluidics market is segmented on the basis of
materials and applications. On the basis of materials, the market is
categorized into polymer-based microfluidics, glass-based microfluidics,
silicon-based microfluidics, and other material-based microfluidics. On the
basis of applications, the microfluidics market is categorized into
pharmaceutical research, in vitro diagnostics, and drug delivery.
The pharmaceutical research application market is further divided into
three major segments, namely, lab analytics (cell-based assays, proteomic
analysis, genomic analysis, and capillary electrophoresis), dispensing, and micro
reaction. The in vitro diagnostics application segment is categorized into
clinical diagnostics, point-of-care testing, environmental testing, industrial
testing, and agro food testing. The drug delivery application segment is
subdivided into inhalers, microneedles, and micro pumps.
You can speak To Research Analyst to Get More Info@
In 2014, the in vitro diagnostics segment accounted for the largest share of the market. Factors such as increasing incidences of chronic diseases, rising aging population, increasing healthcare spending from emerging countries, growing demand for point-of-care testing, emerging technologies like molecular diagnostics, and growing out-of-pocket healthcare spending are boosting the growth of the in vitro diagnostics market.
On the basis of regions, North America accounted for the largest share of this market in 2014, followed by Europe, Asia-Pacific, and RoW. However, the Asia-Pacific region is the fastest-growing market for microfluidics products, primarily due to the rising aging population and increasing R&D and healthcare expenditure in this region. In addition, large-scale improvements in the healthcare infrastructure of countries such as China, Taiwan, and India are propelling the growth of this market.
Major players in the global microfluidics market include Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.).
Browse Related Reports:
Nanotechnology in Medical Devices Market by Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research) - Global Forecast to 2019.
In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] – Forecast To 2020.
is the world’s No. 2 firm in terms of annually published premium market
research reports. Serving 1700 global fortune enterprises with more than 1200
premium studies in a year, M&M is catering to a multitude of clients across
8 different industrial verticals. We specialize in consulting assignments and
business research across high growth markets, cutting edge technologies and
newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
flagship competitive intelligence and market research platform, "RT"
connects over 200,000 markets and entire value chains for deeper understanding
of the unmet insights along with market sizing and forecasts of niche markets.
The new included chapters on Methodology and Benchmarking presented with high
quality analytical infographics in our reports gives complete visibility of how
the numbers have been arrived and defend the accuracy of the numbers.
MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.
Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets